These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 31989649
1. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells. Mansoori B, Mohammadi A, Abedi-Gaballu F, Abbaspour S, Ghasabi M, Yekta R, Shirjang S, Dehghan G, Hamblin MR, Baradaran B. J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649 [Abstract] [Full Text] [Related]
2. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer. Anjum S, Naseer F, Ahmad T, Jahan F, Qadir H, Gul R, Kousar K, Sarwar A, Shabbir A. Sci Rep; 2024 May 19; 14(1):11431. PubMed ID: 38763930 [Abstract] [Full Text] [Related]
3. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo. Jian YS, Chen CW, Lin CA, Yu HP, Lin HY, Liao MY, Wu SH, Lin YF, Lai PS. Int J Nanomedicine; 2017 May 19; 12():2315-2333. PubMed ID: 28392690 [Abstract] [Full Text] [Related]
4. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation. Liu K, Wang ZQ, Wang SJ, Liu P, Qin YH, Ma Y, Li XC, Huo ZJ. Int J Nanomedicine; 2015 May 19; 10():6445-54. PubMed ID: 26491300 [Abstract] [Full Text] [Related]
5. Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines. Shnaikat SG, Shakya AK, Bardaweel SK. Saudi Pharm J; 2024 Jul 19; 32(7):102099. PubMed ID: 38817822 [Abstract] [Full Text] [Related]
6. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44. Wang T, Hou J, Su C, Zhao L, Shi Y. J Nanobiotechnology; 2017 Jan 10; 15(1):7. PubMed ID: 28068992 [Abstract] [Full Text] [Related]
7. A novel design of HA-coated nanoparticles co-encapsulating plasmid METase and 5-Fu shows enhanced application in targeting gastric cancer stem cells. Yang W, Zhang H, Xin L. Biol Chem; 2018 Feb 23; 399(3):293-303. PubMed ID: 29016350 [Abstract] [Full Text] [Related]
8. Hyaluronidase Enzyme-responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer. Jiang H, Shi X, Yu X, He X, An Y, Lu H. Pharm Res; 2018 Feb 23; 35(4):73. PubMed ID: 29476264 [Abstract] [Full Text] [Related]
9. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy. Wang J, Muhammad N, Li T, Wang H, Liu Y, Liu B, Zhan H. Mol Pharm; 2020 Jul 06; 17(7):2411-2425. PubMed ID: 32437163 [Abstract] [Full Text] [Related]
10. Targeted Nanoparticles for Co-delivery of 5-FU and Nitroxoline, a Cathepsin B Inhibitor, in HepG2 Cells of Hepatocellular Carcinoma. Varshosaz J, Fard MM, Mirian M, Hassanzadeh F. Anticancer Agents Med Chem; 2020 Jul 06; 20(3):346-358. PubMed ID: 31566137 [Abstract] [Full Text] [Related]
11. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Nair K L, Jagadeeshan S, Nair SA, Kumar GS. Int J Nanomedicine; 2011 Jul 06; 6():1685-97. PubMed ID: 21980233 [Abstract] [Full Text] [Related]
12. Hyaluronic acid-conjugated methotrexate and 5-fluorouracil for targeted drug delivery. Shao W, Yang Y, Shen W, Ren L, WenwenWang, Zhu P. Int J Biol Macromol; 2024 Jul 06; 273(Pt 1):132671. PubMed ID: 38823747 [Abstract] [Full Text] [Related]
13. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK, Agarwal A, Rai G, Mishra P, Jain S, Mishra AK, Agrawal H, Agrawal GP. Drug Deliv; 2010 Nov 06; 17(8):561-72. PubMed ID: 20738221 [Abstract] [Full Text] [Related]
14. Incorporating mannose-functionalized hydroxyapatite/metal-organic framework into the hyaluronic acid hydrogel film: A potential dual-targeted oral anticancer delivery system. Poursadegh H, Bakhshi V, Amini-Fazl MS, Adibag Z, Kazeminava F, Javanbakht S. Int J Biol Macromol; 2024 Aug 06; 274(Pt 2):133516. PubMed ID: 38944078 [Abstract] [Full Text] [Related]
15. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer. Sen K, Banerjee S, Mandal M. Colloids Surf B Biointerfaces; 2019 Aug 01; 180():9-22. PubMed ID: 31015105 [Abstract] [Full Text] [Related]
16. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems. Miyazaki M, Yuba E, Hayashi H, Harada A, Kono K. Bioconjug Chem; 2018 Jan 17; 29(1):44-55. PubMed ID: 29183110 [Abstract] [Full Text] [Related]
17. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin. Khaledi S, Jafari S, Hamidi S, Molavi O, Davaran S. J Biomater Sci Polym Ed; 2020 Jun 17; 31(9):1107-1126. PubMed ID: 32249693 [Abstract] [Full Text] [Related]
18. Binding and Internalization in Receptor-Targeted Carriers: The Complex Role of CD44 in the Uptake of Hyaluronic Acid-Based Nanoparticles (siRNA Delivery). Rios de la Rosa JM, Pingrajai P, Pelliccia M, Spadea A, Lallana E, Gennari A, Stratford IJ, Rocchia W, Tirella A, Tirelli N. Adv Healthc Mater; 2019 Dec 17; 8(24):e1901182. PubMed ID: 31738017 [Abstract] [Full Text] [Related]
19. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy. Gautam M, Thapa RK, Gupta B, Soe ZC, Ou W, Poudel K, Jin SG, Choi HG, Yong CS, Kim JO. Expert Opin Drug Deliv; 2020 Mar 17; 17(3):423-434. PubMed ID: 32028805 [Abstract] [Full Text] [Related]
20. Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis. Chong D, Ma L, Liu F, Zhang Z, Zhao S, Huo Q, Zhang P, Zheng H, Liu H. Anticancer Drugs; 2017 Sep 17; 28(8):831-840. PubMed ID: 28816773 [Abstract] [Full Text] [Related] Page: [Next] [New Search]